Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Shionogi has received US FDA approval for XOCOVA, or ensitrelvir, as an oral post-exposure prophylaxis option for COVID-...
Eli Lilly has reported detailed Phase III results from three ACHIEVE trials evaluating Foundayo, or orforglipron, an ora...
US-based Phenomenex Inc., a Danaher Company and a global leader in the research and manufacture of advanced technologies...
Otsuka has reported positive interim Phase III VISIONARY data showing that VOYXACT preserved kidney function over 12 mon...
SGS has acquired CMIC, INC., a specialised bioanalytical testing services provider based in Chicago, Illinois, strengthe...
Johnson & Johnson has received US FDA approval for a supplemental Biologics License Application to include evidence ...
Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...
Shanghai Henlius Biotech and Organon have received European Commission marketing authorisation for POHERDY, a pertuzumab...
Medable Inc., the leading technology platform for agentic AI-powered clinical development, today announced its Agentic A...
SCIEX, a Danaher company and leader in life science analytical technologies, has launched the novus V55 system - a next-...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the Thermo Scientific Orbitrap...
Waters Corporation has announced that the BD BACTEC FXI Culture System has received US Food and Drug Administr...
Thermo Fisher Scientific Inc., the world leader in serving science, has expanded its suite of Thermo Scientific™ O...
US-based Eli Lilly and Company has announced agreements to acquire three companies, Curevo Inc., LimmaTech Biologic...
Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies advance toward broader commercial adoption, the industry faces mounting pre...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
What were the key takeaways for Hongene after attending TIDES USA 2026? TIDES USA 2026 reinforced several themes that w...
Renaissance BioScience Corp., a global leader in bioengineered yeast, today announced the filing of a provisional ...
US-based Cytiva, a Danaher company, is introducing the next generation of its Biacore 8 series SPR systems, enabling sci...
Nutraceutical ingredients innovator SUANNUTRA USA has inked a distribution agreement with Spanish biotech company Fitopl...
Fujifilm Healthcare Americas Corporation, owned by Japan-based Fujifilm Holdings Corporation, has announced the launch o...
New platform leverages the established Curator® platform methodology to industrialize Lentivirus processes from conc...
Taiwan-based Bora Pharmaceuticals announced that its Board of Directors has approved the acquisition of the GMP manufact...
